Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 102 (LINC00102)
- Target
- LINC00102
- Molecular classification
- Other, long non-coding RNA (lncRNA), non-protein coding RNA
01
Overview
LINC00102 (long intergenic non-protein coding RNA 102) is a human long non-coding RNA molecule, denoted by HGNC symbol LINC00102 and also referenced as NCRNA00102. It does not code for proteins and belongs to the class of lncRNAs, which are generally involved in regulatory roles in gene expression or chromatin organization. There is currently no evidence for its use or recognition as a therapeutic target, nor direct implication in major disease pathways or interactions with pharmaceutical agents.
- Other names
- NCRNA00102LINC00102
02
Mechanism of action
None — Since no drugs target LINC00102, there is no defined mechanism of action.
03
Biological functions
The precise functions of LINC00102 remain poorly characterized; as a lncRNA, it may play regulatory roles in transcription or chromatin, but direct evidence is lacking. No well-established role in canonical cell signaling or disease mechanisms is documented.
04
Disease associations
None established — There is no strong evidence associating LINC00102 with a specific disease such as cancer, inflammation, or other major disease categories in curated resources.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 102 (LINC00102).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 102 (LINC00102).